Air flow resistance of three heat and moisture exchanging filter designs under wet conditions: implications for patient safety.

Heat and moisture exchanging filters (HMEFs) can be blocked by secretions. We have studied HMEF performance under wet conditions to see which particular design features predispose to this complication. Dar Hygrobac-S (composite felt filter and cellulose exchanger), Dar Hygroster (composite pleated ceramic membrane and cellulose exchanger) and Pall BB22-15 (pleated ceramic membrane) HMEFs were tested. Saline retention, saline concealment, and changes in air flow resistance when wet were assessed. The cellulose exchanger in the composite Hygrobac-S and Hygroster retained saline, producing a 'tampon' effect, associated with bi-directional air flow resistances in excess of the international standard of a 5 cm H(2)O pressure drop at 60 litre min(-1) air flow. Furthermore, high air flow resistances occurred before free saline was apparent within the transparent filter housing. The pleat only BB22-15 showed a significant increase in expiratory air flow resistance, but only after the presence of saline was apparent. These data imply that composite HMEFs with cellulose exchangers are more likely to block or cause excessive work of breathing as a result of occult accumulation of patient secretions than pleat only HMEFs.

Nitrous oxide sedation causes post-hyperventilation apnoea.

We have studied, in six normal subjects, the effect of nitrous oxide sedation on the ventilatory pattern and oxygen saturation using pulse oximetry (SpO2) after hyperventilation to an end-tidal carbon dioxide partial pressure (PE'CO2) of 3 kPa. This value of PE'CO2 was shown to be less than the apnoeic threshold of all these subjects when their ventilation vs PE'CO2 response curves were plotted. All subjects became apnoeic when told to relax following hyperventilation while breathing 75% nitrous oxide for 90 s. Apnoea was defined as cessation of breathing for 20 s or more. The mean duration of apnoea was 78 s (range 29-130 s). All subjects demonstrated arterial desaturation (mean SpO2 75%, range 44-87%). In contrast, following hyperventilation with air, no apnoea was seen in any subject, although there was some evidence of desaturation (mean SpO2 92.5%, range 88-98%). It was concluded that subjects who are sedated with nitrous oxide behave similarly to those who are anaesthetized rather than to those who were fully conscious, in that they become apnoeic below the apnoeic threshold point. The reduction in SpO2 after hyperventilation was explained almost entirely by apnoea and may explain abnormalities of respiratory control and hypoxaemia in patients recovering from general anaesthesia or sedation accompanied by hypocapnia. This mechanism may be of importance in obstetric patients after breathing Entonox, when apnoea and hypoxaemia may reduce oxygen delivery to the fetus.

Modification by alfentanil of the haemodynamic response to tracheal intubation in elderly patients. A dose-response study.

Fifty-five elderly patients undergoing elective ophthalmological surgery were randomly allocated to four groups. Following the induction of anaesthesia with thiopentone (given over 2 min) and the administration of atracurium 0.6 mg kg-1, patients received alfentanil 400, 600, 800 or 1000 micrograms. Intubation of the trachea was performed 90 s later. Heart rate was monitored continuously and systolic arterial pressure was measured at 1-min intervals for 3 min before induction, and both variables were monitored until 10 min had elapsed after tracheal intubation. In each of the groups there was a significant decrease in systolic arterial pressure and a significant increase in heart rate on induction of anaesthesia. In those patients who received either 400 or 600 micrograms of alfentanil, arterial pressure increased immediately after tracheal intubation, whereas in those receiving alfentanil 800 or 1000 micrograms, arterial pressure decreased immediately after tracheal intubation, and when measured 10 min after intubation. It is suggested that alfentanil 600 micrograms (10 micrograms kg-1) constitutes the optimal dose with which to obtund the haemodynamic response to tracheal intubation in elderly patients, and to minimize cardiovascular depression after tracheal intubation.